Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
12112studies shown
Showing 5,941-5,952 of 12,112
Drug study icon
TerminatedNCT05254405

An Open Label Study of IV Brexanolone for PTSD

This study has public registry information. It focuses on PTSD and currently lists study information in the United States.

In Austin
PTSDDrugA study involving a medication or substance.From 18 Years to 50 Years
Countries
United States
Sponsor
Donald Jeffrey Newport
Condition
PTSD
Drug study icon
Active Not RecruitingNCT04433858

Safety and Efficacy of Psilocybin for treatment-resistant depression

This study is active but not recruiting in the United States. It is testing safety and Efficacy of Psilocybin for treatment-resistant depression.

Multiple locations, including Palo Alto
DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sheppard Pratt Health System
Condition
Depression
Device study icon
CompletedNCT02640950

An Open Label study of TMS Therapy for Depression in bipolarity

This study is completed. It focuses on bipolarity and currently lists study information in the United States.

Multiple locations, including Baltimore
Bipolarity, DepressionOtherOver 18 Years
Countries
United States
Sponsor
Sheppard Pratt Health System
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.